Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mouse models of tuberous sclerosis complex.

Danielle K Scheidenhelm1, David H Gutmann

  • 1Department of Neurology, Washington University School of Medicine, St Louis, MO 63110, USA.

Journal of Child Neurology
|November 26, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nested pediatric low-grade glioma cerebral organoid avatars reveal glutamatergic neuron stromal growth dependency.

Genes & development·2026
Same author

Differences in Optic Pathway Glioma Prevalence Among Children with Neurofibromatosis Type 1.

The Journal of pediatrics·2026
Same author

Central Precocious Puberty and Optic Pathway Glioma in Children with Neurofibromatosis 1: Associations with Tumor Location, Vision, and Treatment.

The Journal of pediatrics·2026
Same author

Nested ecosystems theory for conceptualizing brain tumors.

Disease models & mechanisms·2026
Same author

Time trends in the male to female ratio for autism incidence: population based, prospectively collected, birth cohort study.

BMJ (Clinical research ed.)·2026
Same author

Head-to-head preclinical treatment design prioritizes promising therapies for neurofibromatosis type 1 optic glioma clinical translation.

Neuro-oncology advances·2026

Tuberous sclerosis complex (TSC) involves brain and organ abnormalities due to TSC1/TSC2 gene mutations. Animal models are crucial for understanding TSC and developing future treatments for affected children.

Area of Science:

  • Genetics and Neuroscience
  • Developmental Biology
  • Medical Genetics

Background:

  • Tuberous sclerosis complex (TSC) is a genetic disorder with severe central nervous system (CNS) complications, including epilepsy, intellectual disability, autism, and glial tumors.
  • Mutations in TSC1 or TSC2 genes disrupt the hamartin-tuberin protein complex, leading to abnormal cell behavior and characteristic brain lesions (cortical tubers).

Purpose of the Study:

  • To investigate the cellular and molecular mechanisms underlying TSC pathogenesis.
  • To highlight the utility of animal models in studying TSC and developing therapeutic strategies.

Main Methods:

  • Utilized conventional and conditional knockout mouse models to study the functions of TSC1 (hamartin) and TSC2 (tuberin) genes.
  • Examined the impact of gene disruption on cellular differentiation, migration, and proliferation in the brain.

Related Experiment Videos

Main Results:

  • Demonstrated that TSC1/TSC2 gene mutations disrupt the hamartin-tuberin signaling complex.
  • Observed abnormal cellular processes in the brain, leading to the formation of cortical tubers, consistent with TSC pathology.

Conclusions:

  • Animal models are essential for understanding the diverse clinical manifestations of TSC.
  • These models hold significant promise as preclinical tools for developing targeted and effective treatments for TSC patients, particularly children.